Step 4: Monitoring / You will monitor your blood sugar closely at home
About this article Cite this article Suresh, J., Vivekanandan, K
There is also a 5-year Phase III clinical trial (NCT04822181) underway to investigate the efficacy and safety of semaglutide monotherapy in patients with NASH without cirrhosis, assessing the primary endpoints of progression of cirrhosis, regression of steatohepatitis, inflammation, and histological changes in balloon-like hepatocytes
The GLP-1 receptor activation also reduces appetite and food intake through central nervous system pathways, contributing to significant weight loss observed in clinical trials
We believe that a good approach is, theres a lot of federal regulation, theres a lot of state regulation, theres a lot of international standards that exist